Literature DB >> 28540934

Monozygotic twins discordant for primary aldosteronism: a case report.

Y Kobayashi1,2,3,4, K Yatsu3, K Nakata-Shimokihara5, N Inoue5, T Fujikawa6, N Hirawa7, S Umemura8, F Satoh9, G P Rossi4, K Tamura3.   

Abstract

Mesh：

Year:  2017        PMID： 28540934     DOI： 10.1038/jhh.2017.41

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  10 in total

1.  A case of monozygotic twins with primary aldosteronism: a case report.

Authors:  T Yoshida; Y Uchiwa; K Sugimachi; M Naruse
Journal:  J Hum Hypertens       Date:  2017-02-02       Impact factor: 3.012

2.  Isoform-specific monoclonal antibodies against 3β-hydroxysteroid dehydrogenase/isomerase family provide markers for subclassification of human primary aldosteronism.

Authors:  Masao Doi; Fumitoshi Satoh; Takashi Maekawa; Yasuhiro Nakamura; Jean-Michel Fustin; Motomi Tainaka; Yunhong Hotta; Yukari Takahashi; Ryo Morimoto; Kei Takase; Sadayoshi Ito; Hironobu Sasano; Hitoshi Okamura
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

Review 3.  Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney.

Authors:  Michael Stowasser; Richard D Gordon
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

4.  Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells.

Authors:  Monika Ehrhart-Bornstein; Karen Arakelyan; Alexander W Krug; Werner A Scherbaum; Stefan R Bornstein
Journal:  Endocr Res       Date:  2004-11       Impact factor: 1.720

5.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

6.  Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients.

Authors:  Gian Paolo Rossi; Anna Belfiore; Giampaolo Bernini; Bruno Fabris; Graziella Caridi; Claudio Ferri; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Massimo Mannelli; Gaetana Palumbo; Anna Patalano; Damiano Rizzoni; Ermanno Rossi; Achille C Pessina; Franco Mantero
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

7.  Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.

Authors:  Tony C Pang; Chris Bambach; Judith C Monaghan; Stan B Sidhu; Alex Bune; Leigh W Delbridge; Mark S Sywak
Journal:  ANZ J Surg       Date:  2007-09       Impact factor: 1.872

8.  Genetics of primary aldosteronism.

Authors:  John W Funder
Journal:  Front Horm Res       Date:  2014-06-10       Impact factor: 2.606

9.  Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.

Authors:  Sébastien Savard; Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

10.  Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.

Authors:  Gian Paolo Rossi; Maurizio Cesari; Cesare Cuspidi; Giuseppe Maiolino; Maria Verena Cicala; Valeria Bisogni; Franco Mantero; Achille C Pessina
Journal:  Hypertension       Date:  2013-05-06       Impact factor: 10.190
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.